US Stock MarketDetailed Quotes

MLAB Mesa Laboratories

Watchlist
  • 118.450
  • +0.450+0.38%
Close Nov 4 16:00 ET
  • 118.450
  • 0.0000.00%
Post 16:02 ET
640.72MMarket Cap-2548P/E (TTM)

About Mesa Laboratories Company

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.

Company Profile

SymbolMLAB
Company NameMesa Laboratories
Listing DateMar 2, 1984
Founded1982
CEOMr. Gary M. Owens
MarketNASDAQ
Employees736
Fiscal Year Ends03-31
Address12100 West 6th Avenue
CityLakewood
ProvinceColorado
CountryUnited States of America
Zip Code80228
Phone1-303-987-8000

Company Executives

  • Name
  • Position
  • Salary
  • Gary M. Owens
  • Director, President and Chief Executive Officer
  • 5.44M
  • John V. Sakys
  • Vice President, Chief Financial Officer, Chief Accounting Officer and Treasurer
  • 1.94M
  • Brian David Archbold
  • Senior Vice President, Operations and Continuous Improvement
  • 1.62M
  • Dr. John J. Sullivan, PhD
  • Chairman of the Board
  • 255.13K
  • Shiraz S. Ladiwala
  • Lead Independent Director
  • 220.03K
  • R. Tony Tripeny
  • Independent Director
  • 220.13K
  • Shannon M. Hall
  • Independent Director
  • 220.13K
  • Jennifer S. Alltoft
  • Independent Director
  • 220.13K
  • Mark Christopher Capone
  • Independent Director
  • 90.03K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data